Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Palvella Therapeutics (PVLA) vs. Competitors

805 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
PVLAPalvella Therapeutics$142.85$2.13B-25.9756.05%Strong BuyUnlock the PVLA analyst price target with TipRanks PremiumPVLAUnlock the PVLA top-analyst price target with TipRanks Premium
MNPRMonopar Therapeutics Inc$69.00$476.34M-26.74-16.87%Strong BuyUnlock the MNPR analyst price target with TipRanks PremiumPVLA vs MNPRUnlock the MNPR top-analyst price target with TipRanks Premium
NRIXNurix Therapeutics$12.85$1.49B5.12-16.18%Strong BuyUnlock the NRIX analyst price target with TipRanks PremiumPVLA vs NRIXUnlock the NRIX top-analyst price target with TipRanks Premium
TYRATyra Bioscience$20.12$1.36B-7.62-4.19%Strong BuyUnlock the TYRA analyst price target with TipRanks PremiumPVLA vs TYRAUnlock the TYRA top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PVLAPalvella Therapeutics142.8548.7651.82%
MNPRMonopar Therapeutics Inc69.00-22.56-24.64%
NRIXNurix Therapeutics12.85-3.91-23.33%
TYRATyra Bioscience20.12-1.00-4.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts